Literature DB >> 21935720

Bilateral symmetrical cortical osteolytic lesions in two patients with Gaucher disease.

Ian M Oppenheim1, Astrid Medina Canon, William Barcenas, Catherine Groden, Ozlem Goker-Alpan, Charles S Resnik, Ellen Sidransky.   

Abstract

Gaucher disease (GD) is an autosomal recessive lysosomal storage disorder characterized by the reduced or absent activity of glucocerebrosidase. The disease is split into three types. Type 3, or chronic neuronopathic GD, manifests with heterogeneous clinical presentations. Skeletal manifestations of GD can include abnormal bone remodeling resulting in the characteristic Erlenmeyer flask deformities, painful bone crises, osteopenia, and an increased frequency of fractures. Osteolytic lesions can also occur but are rare and tend to be large, expanding intramedullary lesions with cortical thinning. We present two adolescent patients with type 3 GD who developed bilateral symmetrical cortical osteolytic lesions. The lesions in both cases demonstrate predominant cortical scalloping with fairly indolent growth. Neither patient manifests some of the more common bony manifestations of GD--bone crises or osteonecrosis. These atypical and unique skeletal findings in two unrelated probands with type 3 GD further expand the extent of phenotypic variation encountered in this single gene disorder.

Entities:  

Mesh:

Year:  2011        PMID: 21935720      PMCID: PMC3348707          DOI: 10.1007/s00256-011-1260-x

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  6 in total

Review 1.  Enzyme therapy for lysosomal storage disease: principles, practice, and prospects.

Authors:  Gregory A Grabowski; Robert J Hopkin
Journal:  Annu Rev Genomics Hum Genet       Date:  2003       Impact factor: 8.929

2.  Osseous manifestations of adult Gaucher disease in the era of enzyme replacement therapy.

Authors:  Patrick B Deegan; Elena Pavlova; Jane Tindall; Penelope E Stein; Philip Bearcroft; Atul Mehta; Derralynn Hughes; J Edmund Wraith; Timothy M Cox
Journal:  Medicine (Baltimore)       Date:  2011-01       Impact factor: 1.889

Review 3.  An overview on bone manifestations in Gaucher disease.

Authors:  Peter Mikosch; Derralynn Hughes
Journal:  Wien Med Wochenschr       Date:  2010-12

4.  Type 1 Gaucher disease presenting with extensive mandibular lytic lesions: identification and expression of a novel acid beta-glucosidase mutation.

Authors:  M P Wasserstein; J A Martignetti; R Zeitlin; H Lumerman; M Solomon; M E Grace; R J Desnick
Journal:  Am J Med Genet       Date:  1999-06-04

Review 5.  Cellular pathology of lysosomal storage disorders.

Authors:  S U Walkley
Journal:  Brain Pathol       Date:  1998-01       Impact factor: 6.508

6.  Pathologic gene expression in Gaucher disease: up-regulation of cysteine proteinases including osteoclastic cathepsin K.

Authors:  M T Moran; J P Schofield; A R Hayman; G P Shi; E Young; T M Cox
Journal:  Blood       Date:  2000-09-01       Impact factor: 22.113

  6 in total
  4 in total

Review 1.  Diagnosing neuronopathic Gaucher disease: New considerations and challenges in assigning Gaucher phenotypes.

Authors:  Emily C Daykin; Emory Ryan; Ellen Sidransky
Journal:  Mol Genet Metab       Date:  2021-01-09       Impact factor: 4.797

2.  Bilateral Femoral Osteolytic Lesions in a Patient with Type 3 Gaucher Disease.

Authors:  Enock Teefe; Jenny Kim; Grisel Lopez; Ellen Sidransky
Journal:  Mol Genet Metab Rep       Date:  2015-12-01

3.  Symmetric, bilateral upper and lower extremity lucent lesions in a patient with Gaucher's disease on enzyme replacement therapy.

Authors:  Andrew S Kuhn; Lovemore P Makusha; Syed A Jamal Bokhari
Journal:  Radiol Case Rep       Date:  2020-09-03

4.  The natural history of type 2 Gaucher disease in the 21st century: A retrospective study.

Authors:  Tamanna Roshan Lal; Gurpreet K Seehra; Alta M Steward; Chelsie N Poffenberger; Emory Ryan; Nahid Tayebi; Grisel Lopez; Ellen Sidransky
Journal:  Neurology       Date:  2020-08-06       Impact factor: 9.910

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.